Live Breaking News & Updates on Lreadya Market Leader In Providing Advanced Genetic And Genomic Testing Services For Prenatal Newborns

Bangalore (Karnataka) [India], December 2 (ANI/PRNewswire): As part of its evolution into a full-stack Omni-Channel, Healthcare services platform MFine in a joint venture with LifeCell Diagnostics, India's leading genetic testing services provider, today announced the expansion of its offline footprint with the opening of the 100th Patient Service Center (PSC). The companies in July this year announced a joint venture LifeWell, including an $80Mn fundraise from OrbiMed Asia. The PSC has facilities for sample collection for blood tests along with assisted teleconsultations, booking for imaging/radiology tests at neighborhood centers and home delivery of medicines. The company seeks to rapidly expand its network from already established 25+ MFine branded pathology labs and 100+ experience centers across 15+ cities to a network of 50+ labs and 500+ patient service centers across 30+ cities covering pathology, radiology, and genomics by March 2023. To execute on this the company shall ....

Tamil Nadu , Prasad Kompalli , Ashutosh Lawania , Mayur Abhaya , Ajit Narayanan , Arjun Choudhary , Orbimed Asia , Health Solutions Pathology Private , Patient Service Center , Lifecell International Pvt Ltd , Lifecell Diagnostics , Mumbai Based Health Solutions Pathology Private , Cell Diagnostics , Bangalore Karnataka India , Ecember 2 Ani Prnewswire As Part Of Its Evolution Intoa Full Stack Omni Channel , Ealthcare Services Platform Mfine Ina Joint Venture With Lifecell Diagnostics , Ndia 39s Leading Genetic Testing Services Provider , Oday Announced The Expansion Of Its Offline Footprint With Opening 100th Patient Service Center Psc Companies In July This Year Announceda Joint Venture Lifewell , Ncluding An 80mn Fundraise From Orbimed Asia The Psc Has Facilities For Sample Collection Blood Tests Along With Assisted Teleconsultations , Ooking For Imaging Radiology Tests At Neighborhood Centers And Home Delivery Of Medicines The Company Seeks To Rapidly Expand Its Network From Already Established 25 Mfine Branded Pathology Labs 100 Experience Across 15 Cities Toa 50 500 Patient Service 30 Covering , Nd Genomics By March 2023 To Execute On This The Company Shall Support Organic Building Up Ofa Nationwide Lab Network Also Onboarding Existing High Quality Radiology And Pathology Assets Througha Roll Process Towards That , He Company Has Already Completed The Integration Of Mumbai Based Health Solutions Pathology Private Limited With This Rapid Expansion , Fine Will Be Providinga Seamless Omni Channel Experience Of Consuming Healthcare Services The High Density Network Enables Fast , Ccurate And High Quality Diagnostics Services Which Can Be Availed From Either At Home Or Center The Company Already Launched Their Acute Care Service Mfine Now Wherein One Get Blood Samples Collected Within An Hour Of Bookinga Test , Nd Reports Reach The Patient And His Her Doctor Within 6 Hours Mfine Continues To Be One App For All Health Needs Of Users With Seamless Integration Across Tele Consultations , Diagnostic Tests ,